Tag: Antibacterial spectrum

Fluoroquinolones are a class of broad-spectrum antibiotics that have evolved significantly since the 1960s, with newer generations expanding their antimicrobial activity. This powerful class of drugs works by inhibiting bacterial DNA synthesis and is effective against a wide array of pathogens, but exactly what bacteria are covered by fluoroquinolones varies depending on the specific drug and its generation.

Approved by the FDA in 2017 for acute bacterial skin and skin structure infections (ABSSSI), delafloxacin is a novel fluoroquinolone antibiotic. Understanding **what does delafloxacin cover** is crucial, as its potent broad-spectrum activity, particularly against methicillin-resistant Staphylococcus aureus (MRSA), sets it apart from older agents in its class.